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1. Introduction 
Intracranial aneurysms (IAs) occur in 0.2%-9% of adults (18, 35, 54). This wide range 
probably reflects methodological differences between studies: prospective or retrospective 
designs, diagnostic tools (angiography or autopsy) and study populations. IAs are present 
with subarachnoid haemorrhage (SAH) in the majority of cases. Aneurismal subarachnoid 
haemorrhage is a sudden and often catastrophic event with high mortality and morbidity 
rates: 15% die before hospitalisation and 36% die within 48 hours of its onset, 43% in the first 
week and 57% within six months (3). Furthermore, half of the survivors manifest physical or 
psychosocial deficits one year after SAH (22). 
In the USA, it is estimated that SAH accounts for over 25% of all stroke-related years of 
potential life lost before the age of 65 (37). In Japan, SAH inflicts as many people as 
automobile accidents (AMA), about 13,000 per year (60). Recent improvements in the 
management of patients with aneurismal SAH have slightly reduced fatality rates over the 
last three decades (28). However, the severity of the initial bleeding and the clinical 
condition of the patients following SAH remain the main predictors for their outcome. 
Therefore, we believe that the treatment of unruptured aneurysms and the prevention of 
their formation and progression represent the best practical measures to avoid the grim 
outcomes of SAH. This requires a good understanding of the pathogenesis of IAs and the 
role of the various risk factors in their formation and progression. 
2. Definition of cerebral aneurysm 
The word aneurysm comes from the Latin word aneurysma, which means dilatation. 
Aneurysm is a persistent localised dilatation of the vessel wall, usually an artery. Saccular 
aneurysms account for the vast majority (98%) of all intracranial aneurysms, and the word 
aneurysm in this work refers to this form. Other types of aneurysms are fusiform, dissecting, 
infectious (mycotic) and traumatic aneurysms. 
Saccular aneurysms consist of three main regions: the neck, the sac and the dome. The neck 
is that part of an aneurysm where it joins the parent artery, while the sac represents the 
cavity of the aneurysm and the dome relates to the convex wall facing the neck of the 
aneurysm. The size of an aneurysm is usually described as the maximum distance between 
the neck and the dome, and more detailed description of an aneurysm’s size requires the 
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measurement of its two dimensions: the maximum distance between the neck and the dome 
and the maximum distance between the sides of the aneurysm (figure 1). Saccular 
aneurysms are specific to the intracranial arteries because their walls lack an external elastic 
lamina and contain very thin adventitia factors that may predispose to the formation of 
aneurysms. An additional feature is that they lie unsupported in the subarachnoid space. 
  
Fig. 1. 3D DSA image of a left ICA showing a left ICA saccular aneurysm, measuring 22.7 
mm (1) X 13.5 mm (2) and projecting medially 
3. Historical background 
The first description of saccular cerebral aneurysm in the medical literature was made in the 
eighteenth century (1761) by Morgagni (58) and Biumi (2), who first described the dilatation 
of the cerebral arteries and showed that their rupture might lead to SAH. Morgagni and 
Biumi’s observations were not further evaluated until 1859, when Sir William Gull (21) 
offered recognition of the pathological nature of the lesion by his often quoted statement: 
"whenever young persons die with apoplexy, and after death a large effusion of blood is 
found, especially if the effusion be over the surface of the brain, in the meshes of the pia 
matter, the presence of aneurysm is probable." 
In 1927, Egas Moniz (57) introduced cerebral angiography to the medical community and 
the clinician finally developed a method to diagnose CA. In 1933, Dott (10) presented a 
series of 8 patients who had undergone angiography with a diagnosis of subarachnoid 
haemorrhage, describing the location of their aneurysms and reporting his operative results. 
This was followed by many reports describing different methods for the management of 
CA, among which was that of Dandy (9) who described a series of 108 patients, 30 of them 
having had an intracranial procedure while others had carotid ligation. The technique of 
angiography is considered to be the key for all research in the field of cerebral aneurysm. 
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4. Epidemiology of cerebral aneurysms 
Intracranial aneurysms are reported to be present in about 5% (range: 0.2%-9.0%) of the 
general population (18, 35, 54). The prevalence figures are clearly related with the method 
employed and the region and population studied. The true prevalence of intracranial 
aneurysms remains unknown, since most aneurysms remain undiagnosed until they 
rupture or produce neurological deficits. In one series of 72 consecutive patients undergoing 
coronary angiography, incidental intracranial aneurysms were found in 5 cases (6.9%) (36); 
another series reported a 2.8% prevalence of asymptomatic incidental aneurysms in 4518 
patients undergoing magnetic resonance angiography (31). Reviewing 3684 cerebral 
arteriograms, Winn et al. reported a 0.65% prevalence of asymptomatic IAs (100). 
A high incidence of IA has been reported in Japan and Finland (14, 36); on the other hand, a 
low incidence was reported in India, Iran, the Middle East and many parts of Africa (39, 61, 
62), and it is difficult to determine whether this regional variation is genuine or related to 
the difference in diagnostic workup among these countries. 
Aneurysms are typically diagnosed in people aged 40-60 years, reaching a peak in people 
aged 55-60 years (23, 60). Intracranial aneurysms are uncommon in children, accounting for 
fewer than 2% of all cases. When aneurysms occur in the paediatric age group, they are 
more often post-traumatic or mycotic rather than degenerative, and they have a slight male 
predilection. Aneurysms in children are also larger than those found in adults (55, 67). 
Cerebral aneurysms affect women more frequently than men. In an autopsy study from Japan, 
the prevalence of aneurysms for women was 2.4 times higher than that for men (35). Among 
men, the prevalence of aneurysms remained unchanged across the range of age groups. In 
contrast, there were 2 peaks in the prevalence of aneurysms for women falling in the 40-49 and 
60-69-year age groups (35). A cerebral angiogram based on a retrospective study showed that 
67% of the patients harbouring asymptomatic aneurysms were women (100). 
5. Location and nomenclature 
Aneurysms commonly arise at the branching site of major arteries. It also occurs at a turn or 
curve of the artery, and points in the direction that the blood would have gone if the curve 
at the aneurysm site were not present (71). Aneurysm is usually referred to by the name of 
the parent artery from which they originate. Cerebral aneurysms occur more frequently in 
arteries of the anterior circulation. In large forensic clinical and autopsy series, the locations 
of intracranial aneurysms are the internal carotid artery (ICA) (24%-41%), the anterior 
cerebral artery (ACA) (30%-39%), the middle cerebral artery (MCA) (20%-33%) and the 
vertebrobasilar arteries (VBA) (4%-12%) (95) (Figure 2). 
6. Presentation of unruptured cerebral aneurysms 
Due to the recent spread of non-invasive diagnostic modalities (CTA and MRA), the 
majority of unruptured IAs are diagnosed incidentally. Here are some specific syndromes 
associated with particular aneurismal locations. 
- Anterior communicating artery: Usually, ACoA aneurysms are silent until they rupture. 
Suprachiasmatic pressure may cause altitudinal visual field deficits, aboulia or akinetic 
mutism, amnestic syndromes and hypothalamic dysfunction.  
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- Anterior cerebral artery: Most are asymptomatic until they rupture, although frontal lobe 
syndromes, anosmia and motor deficits may be noted. 
- Middle cerebral artery: This typically affects the first or second division in the sylvan 
fissure. Aphasia, hemiparesis, hemisensory loss, anosognosia and visual field defects 
may be noted. 
- Posterior communicating artery: These are directed laterally, posteriorly and inferiorly. 
Pupillary dilatation, ophthalmoplegia, ptosis, mydriasis and hemiparesis may result. 
- Internal carotid artery: Supraclinoid aneurysms may cause ophthalmoplegia due to the 
compression of the cranial nerve (CN) III or variable visual defects and optic atrophy 
due to the compression of the optic nerve. Chiasmal compression may produce bilateral 
temporal hemianopsia. Hypopituitarism or anosmia may be seen with giant aneurysms. 
Cavernous-carotid aneurysms exert mass effects within the cavernous sinus, producing 
ophthalmoplegia and facial sensory loss. 
- Basilar artery: The clinical findings are usually those associated with SAH, although 
bitemporal hemianopsia or an oculomotor palsy may occur. Dolichoectatic aneurysms 
may cause bulbar dysfunction, respiratory difficulties and neurogenic pulmonary 
oedema.  
- Vertebral artery or posterior inferior cerebellar artery: Aneurysms at these arterial segments 
typically result in ataxia, bulbar dysfunction or spinal involvement. 
 
Fig. 2. 3D DSA images demonstrating common sites of IAs. A: Right ICA, demonstrating 
right giant ICA saccular aneurysm, measuring 22 mm X 11.8 mm (A). B: Right MCA 
trifurcation aneurysm (26X19 mm). C: Anterior communicating artery small aneurysm.  
D: 3D DSA image of the vertebrobasilar arteries showing basilar top aneurysm measuring 
24X16 
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7. The natural course of incidental aneurysms 
The increased sensitivity of neuroimaging techniques has enabled the more frequent 
diagnosis of unruptured aneurysms. Because the most devastating complication of an 
unruptured aneurysm is subarachnoid haemorrhage, it has been considered desirable to 
treat these aneurysms before they rupture. However, the optimal treatment strategy for 
patients with unruptured aneurysms remains controversial. The management decision 
requires knowledge of the natural history of the patient and an accurate assessment of the 
risks related to various treatment options. 
No consensus exists regarding the natural course of unruptured aneurysms. Unruptured 
aneurysms may remain asymptomatic and static; they may grow and or rupture. On the 
other hand, there are some reports describing the spontaneous regression of aneurysms (82, 
97). 
A systematic review of the literature on the risk of the rupture of aneurysms identified nine 
studies with a total of 3907 patient years of follow-up (72). During follow-up, 75 of 495 
(15.2%) patients suffered an SAH, giving an annual rupture rate of 1.9%. Aneurysms were 
significantly more likely to rupture in women than in men (RR 2.1, 95% CI 1.1-3.9) and the 
risk of rupture increased with age, e.g., in the group of patients aged 60-79 years, the RR of 
rupture was 1.7 (95% CI 0.7-4.0) compared with those aged 40-59 years. The review also 
showed higher RR in symptomatic aneurysms when compared to asymptomatic aneurysms 
(6.5% versus 0.8% respectively) (72). 
The initial size of the intact aneurysm and the subsequent rupture rate is a complex issue. In 
Juvela's study (38), there was no disparity in the size of the aneurysm on digital subtraction 
angiography (DSA) at the start of follow-up between patients who later had a SAH and 
those who did not (median 4 mm, range 2-25 mm in those with later SAH versus median 4 
mm, range 2-26 mm in those without). Of the aneurysms which later ruptured, 67% were <6 
mm in diameter. 
In a study by Yasui et al., (103) 234 patients with and without SAH were evaluated during a 
period of 6.25 years. Thirty-four patients (14.5%) bled, with an average annual rupture rate 
of 2.3%. In a separate study, these authors evaluated aneurysm size in 25 patients with the 
rupture of a previously unruptured aneurysm (102).Twenty-two of the newly ruptured 
aneurysms were <9 mm in diameter at initial diagnosis, and 16 were <5 mm in diameter. 
The authors concluded that even the smallest UIAs require "radical treatment or careful 
follow-up." 
The largest ever study to follow-up unruptured aneurysms is the ISUIA, with 2621 patients 
(33, 34). This studied two groups of patients retrospectively: (i) patients with asymptomatic 
aneurysms with no prior SAH, and (ii) those with multiple aneurysms who had previously 
sustained an aneurismal SAH. The investigators also studied prospectively the risks of the 
treatment of asymptomatic unruptured aneurysms (34). The results of the ISUIA indicate a 
tiny rupture risk of 0.05% per annum for small aneurysms (<I 0 mm diameter) in patients 
who have not had an SAH previously, and 0.5% per annum for large aneurysms and for all 
aneurysms in patients who had previously sustained SAH from another aneurysm. Of the 
1449 included patients with 1937 unruptured saccular aneurysms <12 mm diameter, 32 
patients had confirmed aneurysm rupture during follow-up; the mean duration of follow-
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up was 8.3 years (12023 patient years in total). In the cohort that had previously not had an 
SAH, only one of 12 aneurismal ruptures occurred in an aneurysm <10 mm in diameter, 
compared with 17 of 20 patients in the cohort who had previously had an SAH. This study 
also found that the only significant predictors of rupture were the size and location of the 
aneurysm: aneurysms >10 mm diameter had an RR of rupture of 11.6; for posterior 
circulation aneurysms, the RR was 13.8 and 13.6 for basilar tip and vertebrobasilar locations, 
respectively, and 8.0 for posterior communicating artery aneurysms. 
The discrepancy in aneurismal rupture rates between the systematic reviews (38, 72, 102, 
103) and the ISUIA (33, 34) requires explanation. The majority of ISUIA patients were 
identified retrospectively from hospital records (1981 onwards, with the identification 
process commencing in 1992) and only survivors with persistently asymptomatic aneurysms 
- in whom a complete set of angiograms could be traced - were eligible for inclusion. These 
patients might not be entirely representative of the natural history of all aneurysms: e.g., 
subjects who had suffered a fatal episode of SAH, or where an asymptomatic aneurysm had 
been treated since 1981, or else who had incomplete angiograms, could not be included in 
the ISUIA. The prospective analysis and follow-up of patients with asymptomatic 
aneurysms provides less biased data. 
Although many authors tried to define a critical size for saccular aneurysm rupture, we 
believe that a critical size below which SAH does not occur does not appear to exist. Other 
risk factors for IA rupture include age, sex, hypertension, and multiple aneurysms and 
previous SAH. Identifying the mechanism of aneurysm formation, growth and rupture will 
explain the role of the various risk factors - including aneurismal size - in the rupture of IAs. 
8. Treatment of unruptured IAs 
Aneurysms may be treated by surgical clipping (or wrapping) or by interventional 
neuroradiology. Surgical treatment, having been in use routinely for >40 years, has fairly 
clearly defined the risks and morbidity. 
A systematic review of surgical treatment for unruptured aneurysms was performed by 
Raaymakers and colleagues, who identified 61 studies including 2460 patients and at least 
2568 aneurysms published between 1966 and June 1996 (69). 
Only studies in which at least 90% of patients were treated by clipping (as opposed to 
wrapping or other surgical techniques) were included. Unfortunately, only eight of the studies 
were prospective, the rest being retrospective and - in virtually all studies - the neurosurgeon 
performing the operation was also the observer of the outcome. The median follow-up was 
only 24 weeks (range 2-234 weeks) in the 21 studies which reported the time of outcome 
assessment. The overall permanent morbidity occurred in 10.9% (95% CI 9.6%-12.2%) of 
patients and mortality was 2.6% (95% CI 2.0%-3.3%). The lowest morbidity and mortality was 
found with small anterior circulation aneurysms (mortality 0.8%, morbidity 1.9%), and the 
worst with large posterior fossa aneurysms (mortality 9.6%, morbidity 37.9%). 
The prospective arm of the ISUIA also addressed the issue of the risks of surgical 
intervention in unruptured aneurysms (34). This enrolled 1172 patients (211 of whom had a 
history of previous SAH) and 996 underwent surgery. The surgery-related mortality at 1 
year was 3.8% (95% CI) in patients with no prior SAH and 2% in patients who had 
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previously suffered an SAH from a different aneurysm which had already been treated. The 
morbidity was 12.0% and 12.1%, respectively. The mortality figures at 1 month in the ISUIA 
study were similar to those in the systematic review, at a median of 24 weeks, 2.3% versus 
2.6%, respectively. Age was the only independent predictor of outcome in the ISUIA study: 
the RR of surgery-related morbidity and mortality at 1 year was X5 in the group >64 years of 
age compared with patients <45 years of age. 
The effectiveness and risks of aneurysm coiling are less certain because the technique is 
newer and still developing. The USA Multicenter Study Group identified a 1% mortality 
and a 4% morbidity for unruptured aneurysm treatment, with 78% of aneurysms being 
completely occluded. The rupture rate of partially coiled aneurysms was 0.5% per annum 
from the limited follow-up data available (91). There is some evidence that even partial 
treatment by GDC confers benefits in the early post-rupture period; post-GDC treatment 
haemorrhage occurred in only nine of 403 patients, although the length of follow-up was 
very limited in many patients (91). 
 
Fig. 3. Demonstrating the enlargement of BA AICA aneurysm following coiling with GDC. 
A: Initial Left VADSA; B: DSA following coiling; C: DSA six months after coiling showing 
coil impaction and enlargement of the aneurismal cavity. 
In the case of an unruptured aneurysm, should one decide treatment was necessary then the 
long-term results of coiling are particularly relevant because coiling could provide a less 
invasive alternative to surgery. It is worth noting that the published rupture rate of partially 
coiled aneurysms is the same as that reported from the ISUIA study for untreated unruptured 
aneurysms >10 mm diameter or for any unruptured aneurysm in a patient with a previous 
SAH. The regrowth rate of partially coiled aneurysms is still being defined, and so there are 
considerable uncertainties about the long- and short-term effectiveness of coiling. 
Apart from direct treatment of the aneurysm, it is likely that there are other ways of 
reducing the risk of rupture for incidentally discovered aneurisms, which could - 
collectively - have a useful effect. The cessation of smoking, careful control of blood pressure 
and the avoidance of risk factors for atherosclerosis (careful diet, regular exercise, etc.), 
while unproven, may help reduce both the risk of formation of aneurysms and the risk of 
rupture, as well as improving general health. 
8.1 Management considerations and recommendations 
Aneurismal SAH is a devastating condition for which prevention has been advocated as the 
most effective strategy aimed at lowering mortality rates. However, all current treatments 
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carry risks, and recommendations for treatment versus observation are often difficult and 
controversial. Treatment complications generally occur at around the time of the procedure, 
but they could potentially improve during the patient's remaining lifetime. In contrast, the 
risk of rupture of an untreated aneurysm is cumulative but may provide a period of 
unimpaired life. Non-lethal complications in both settings can potentially improve over 
time. 
Deliberations must take into account important characteristics of the aneurysm and the 
patient in whom it exists. Of the former, particular consideration must be given to aneurysm 
size, form and location and its symptomatic versus incidental status. As a general rule, 
exclusively extradural, intracavernous (internal carotid artery) aneurysms, even if 
symptomatic with pain or ophthalmoparesis, do not carry a major risk for intracranial 
haemorrhage, and thus management decisions are primarily aimed at symptom relief rather 
than haemorrhage prevention. 
Among patient factors, the patient’s age, general medical condition, previous history of SAH 
and family history of aneurismal SAH are prime considerations in the treatment analysis. 
Symptoms due to UIAs should be discriminated relative to those developing rapidly and 
related to smaller aneurysms, presumably due to acute aneurismal expansion. Generally, 
symptomatic aneurysms are larger, occasionally giant in size and sometimes partially 
thrombosed, producing subacute symptoms due to adjacent cranial nerve or brain 
compression. Such lesions carry a major risk for both progressive neurological deficit and 
aneurysm rupture. 
The existing body of knowledge supports the following recommendations (options) 
regarding the treatment of UIAs: 
1. The treatment of small incidental intracavernous ICA aneurysms is not generally 
indicated. For large symptomatic intracavernous aneurysms, treatment decisions 
should be individualised on the basis of the patient’s age, the severity and progression 
of symptoms and treatment alternatives. The higher risk of treatment and shorter life 
expectancy in older individuals must be considered in all patients, and it favours 
observation in older patients with asymptomatic aneurysms. 
2. Symptomatic intradural aneurysms of all sizes should be considered for treatment, with 
relative urgency for the treatment of acutely symptomatic aneurysms. Symptomatic 
large or giant aneurysms carry higher surgical risks that require a careful analysis of 
individualised patient and aneurismal risks and surgeon and centre expertise. 
3. Coexisting or remaining aneurysms of all sizes in patients with SAH due to another 
treated aneurysm carry a higher risk for future haemorrhage than do similar sized 
aneurysms without a prior SAH history, and they warrant consideration for treatment. 
4. If a decision is made for observation, re-evaluation on a periodic basis with CT/MRA or 
selective contrast angiography should be considered so as to check for changes in 
aneurismal size and shape. 
5. In consideration of the apparent low risk of haemorrhage from incidental small (<10 
mm) aneurysms in patients without previous SAH, treatment rather than observation 
cannot generally be advocated. However, special consideration for treatment should be 
given to young patients in this group. Likewise, small aneurysms approaching the 10 
mm diameter size, those with daughter sac formation and other unique hemodynamic 
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features, and patients with a positive family history for aneurysms or aneurismal SAH 
deserve special consideration for treatment. 
6. Asymptomatic aneurysms of ->10 mm (ISUIA) or >7mm (ISUIA-II) in diameter warrant 
strong consideration for treatment, taking into account the patient’s age, existing 
medical and neurological conditions and the relative risks of treatment.  
These recommendations are based on our limited knowledge concerning the natural history 
of unruptured aneurysm. In our clinical practice, we recommend - whenever possible - the 
active management of these lesions  
9. Subarachnoid haemorrhage (SAH) 
Primary SAH is defined as a bleeding which takes place primarily in the intracranial 
subarachnoid space and is not secondary to some other intracranial haemorrhage (66). In a 
recent systematic review of the literature, the worldwide overall incidence of SAH was 10.5 
per 100,000 person years (85). However, the incidence in Japan was 21.0 per 100,000 person 
years and in Finland it was 22.0 per 100,000 person years (63). The overall incidence of 
aneurismal SAH has remained constant during recent decades (50), but increases almost 
linearly with increasing age (16). 
9.1 The aetiology of SAH 
In more than 80% of cases, the cause of primary SAH is the rupture of an intracranial 
aneurysm (77, 85). SAHs of unknown origin represent 9%-15% of cases (75). The source of 
the bleeding of unknown origin can be the rupture of a small perforating artery or a micro- 
arteriovenous malformation (AVM) which is not identifiable in diagnostic imaging (75). 
Intracranial artery dissections, cerebral AVMs, dural AVMs, trauma, bleeding disorders, 
substance abuse, a spinal origin of the haemorrhage and other rare conditions account for 
primary SAH in less than 5% of cases (85). 
9.2 Clinical presentation 
This is characterised by the acute onset of severe headache, which patients often describe as 
"the worst headache of my life." The sudden elevation of intracranial pressure associated with 
aneurismal rupture may lead to a precipitous decline in cerebral perfusion pressure, causing 
syncope (50% of cases), confusion or mild impairment in alertness. Other symptoms include: 
- Seizures: Focal or generalised seizures are present in 25% of aneurismal SAH cases, 
with most events occurring within 24 hours of onset. 
- Manifestations of meningeal irritation: Neck pain or stiffness, photophobia, sonophobia 
or other hyperesthesia may be noted with SAH. 
- Autonomic disturbances: The subarachnoid accumulation of the products of blood 
degradation may elicit fever, nausea or vomiting, sweating, chills and cardiac 
arrhythmias.  
- Focal neurological complaints: Haemorrhage or ischemia may manifest with focal 
deficits, including weakness, hemisensory loss, language disturbances, neglect, memory 
loss or olfactory disturbances. Focal symptoms are more common with giant 
aneurysms. 
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- Respiratory dysfunction or cardiovascular instability: These are ominous signs of 
brainstem compression. 
- SAH can be associated with myocardial stunning (transient), sometimes with the 
features of tako-tsubo syndrome (transient left ventricular apical ballooning syndrome), 
and with lethal ventricular arrhythmia, all probably caused by SAH-induced 
catecholamine surge. 
The physical examination of patients with aneurismal SAH may reveal nuchal rigidity, a 
decreased level of consciousness, subhyaloid haemorrhages, pupillary abnormalities (i.e., 
typically dilated), ophthalmoplegia, cranial neuropathies and other focal deficits. Giant 
aneurysms may cause mass effects or distal thromboembolism with prominent focal deficits, 
optic atrophy or other cranial neuropathies as well as brainstem compression. 
9.3 The diagnosis of SAH 
CT and MRI 
If SAH is suspected, CT scanning is the first line in investigation because of the 
characteristically hyperdense appearance of extravasated blood in the basal cisterns. The 
pattern of haemorrhage often suggests the location of any underlying aneurysm (86) (Figure 
4). CT studies performed within 12 h after the haemorrhage were found to be negative in 2% 
of patients with SAH (84). 
  
Fig. 4. CT scan of a 47-year-old woman presented with headache and vomiting; her CT scan 
in the emergency department revealed subarachnoid haemorrhage involving the sylvan and 
interhemispheric fissure, the interpeduncular and the ambient cistern. 
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MRI with FLAIR (fluid attenuated inversion recovery) techniques demonstrates SAH in the 
acute phase as reliably as CT (59), but MRI is impracticable because the facilities are less 
readily available than CT scanners, and restless patients cannot be studied unless 
anaesthesia is given. In the subacute cases, however, MRI is increasingly superior to CT in 
detecting SAH (59). 
Lumbar puncture 
Lumbar puncture is still an indispensable step in the exclusion of SAH in patients with a 
convincing history and negative brain imaging. Lumbar puncture should not be carried out 
rashly or without some background knowledge. The first rule is that at least 6 h and preferably 
12 h should have elapsed between the onset of headache and the spinal tap. The delay is 
essential because if there are red cells in the CSF, sufficient lysis will have taken place during 
that time for bilirubin and oxyhaemoglobin to have formed (90). The pigments give the CSF a 
yellow tinge after centrifugation (xanthochromia) - a critical feature in the distinction of SAH 
from a traumatic tap - and are invariably detectable until at least 2 weeks later. The 'three tube 
test' (a decrease in red cells in consecutive tubes) is notoriously unreliable, and a false-positive 
diagnosis of SAH can be almost as invalidating as a missed one. Spinning down the blood-
stained CSF should be done immediately, otherwise oxyhaemoglobin will form in vitro. If the 
supernatant appears crystal-clear, the specimen should be stored in darkness until the absence 
of blood pigments is confirmed by spectrophotometry. 
9.4 Diagnosis of intracranial aneurysm 
The gold standard for detecting aneurysms is conventional angiography, but this is not an 
innocuous procedure. A systematic review of three prospective studies in which patients 
with SAH were distinguished from other indications for catheter angiography found a 
complication rate (transient or permanent) of 1.8% (6). 
Other imaging modalities are MR angiography (MRA) and CT angiography (CTA), which 
are non-invasive. A recent review of studies comparing MRA and intra-arterial angiography 
in patients with recent SAH, under blinded-reader conditions, showed a sensitivity in the 
range of 69%-100% for detecting at least one aneurysm per patient and 70%-97% for the 
detection of all aneurysms, with specificity in the range 75%-100% (93). The sensitivity of 
CTA (compared with catheter angiography) is 85-98%, which is in the same range as that of 
MRA (1). Hashimoto et al, reported the ability of  CTA to detect aneurysms that were 
missed by conventional angiography (25). 
9.5 The grading of SAH 
The Fisher (15) grading method (Table 1) is dependent on findings by CT-scan and has been 
found to be useful in predicting vasospasm after SAH; patients with a thick layer of blood in 
the subarachnoid space were found to have a higher incidence of cerebral vasospasm (46). 
The most common system for grading the clinical condition after SAH is the Hunt and Hess 
(H&H) (32) scale (Table 2). In the original classification according to Hunt&Hess, the patient 
grade was increased by one level in the presence of serious underlying medical disorders. 
On this scale, a higher grade at presentation correlates with increasingly poor clinical 
outcomes. 
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Fisher 
Grade 
Blood on CT No of 
Pts 
Angiographic 
vasospasm 
Clinical 
vasospasm 
1 none 11 4 0 
2 Diffuse or vertical layer >1 mm 
thick 
7 3 0 
3 Localised clot or vertical layer 
>1 mm thick 
24 24 23 
4 Intracerebral or 
intraventricular blood 
5 2 0 
Table 1. The Fisher CT grade 
 
H&H Grade Description
1 Asymptomatic or mild H/A and slight nuchal rigidity 
2 Moderate to severe H/A, nuchal rigidity, no deficit except Cr. N. palsy 
(e.g., III, VI)  
3 Mild focal deficit, lethargy or confusion 
4 Stupor, moderate to severe hemiparesis, early decerebrate rigidity 
5 Deep coma, decerebrate rigidity, moribund appearance 
Add one grade for serious systemic disease (D.M, HTN, Atherosclerosis, COPD) 
Table 2. Hunt and Hess classification of SAH 
In 1987, the World Federation of Neurological Surgeons (WFNS) (70) proposed a new 
grading system (Table 3) in which two factors have been assigned to differentiate grades: 
the level of consciousness - classified with the Glasgow coma scale (GCS) - and focal 
neurological deficits. The timing of the grading is important because the patient's worst 
clinical grade is the best predictor of the outcome. 
 
*Aphasia and/or hemiparesis or hemiplegia  
Table 3. World Federation of Neurologic Surgeons (WFNS) SAH grade 
9.6 The outcome of ruptured intracranial aneurysms 
Case fatality ranged between 32% and 67% in a review of population-based studies from 
1960 onward. The weighted average was 51%. Of patients who survive the haemorrhage, 
approximately one-third remain dependent (28). Recovery to an independent state does not 
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necessarily mean that the outcome is good. In a study of quality of life in patients after SAH, 
only 9 of 48 (19%; 95% CI 9%-33%) patients who were independent 4 months after the 
haemorrhage had no significant reduction in quality of life (29). All in all, only a small 
minority of all patients with SAH have a truly good outcome. The relatively young age at 
which SAH occurs and its poor outcome together explain why the loss of years of potential 
life before the age of 65 from SAH is comparable to that of ischaemic stroke (37). 
Factors that influence prognosis 
The predictors for mortality include the patient's decreased level of consciousness, their 
increased age, the thickness of the subarachnoid haemorrhage clot on computerised 
tomography, elevated blood pressure, pre-existing medical illnesses and basilar aneurysms 
(42, 79). A decreased level of consciousness, with the initial haemorrhage or after early 
rebleeding, may be caused by intracerebral haematoma, subdural haematoma or 
hydrocephalus. Only by exclusion should it be assumed that the cause is global brain 
damage as a result of high pressure and subsequent ischaemia.  
Rebleeding 
In the first few hours after admission for the initial haemorrhage, up to 15% of patients have 
a sudden episode of clinical deterioration that suggests rebleeding (17). As such, sudden 
episodes often occur before the first CT scan, or even before admission to hospital - a firm 
diagnosis is difficult and the true frequency of rebleeding on the first day is invariably 
underestimated. 
In the prospective Cooperative Aneurysm Study (44), the risk of rebleeding with 
conservative therapy was highest (4%) on the first day after SAH and then remained 
constant at a rate of 1%-2% per day during the subsequent two weeks. In his earlier series, 
Pakarinen (66) reported a cumulative frequency of rebleeding of 7%, 16%, 23% and 33% at 
week 1, week 2, week 3 and week 4 respectively. The mortality at first recurrence was 63.6%, 
and at second recurrence it had risen to 86%.  
Intracerebral haematoma 
Intraparenchymal haematomas occur in up to 30% of patients with ruptured aneurysms 
(87). Not surprisingly, the average outcome is worse than in patients with purely 
subarachnoid blood (26). When a large haematoma is the most likely cause of the poor 
condition on admission, the immediate evacuation of the haematoma should be seriously 
considered (with simultaneous clipping of the aneurysm if it can be identified), often with 
the aneurysm having been demonstrated only by MR angiography or CT angiography. 
Acute subdural haematoma 
An acute subdural haematoma, which is usually associated with recurrent aneurismal 
rupture, but can also occur with the initial haemorrhage, may be life threatening; in these 
cases, immediate evacuation is also called for (65).  
Acute hydrocephalus 
Gradual obtundation within 24 h of haemorrhage, sometimes accompanied by slow 
pupillary responses to light and downward deviation of the eyes, is fairly characteristic of 
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acute hydrocephalus (73). If the diagnosis is confirmed by CT, this can be a reason for early 
ventricular drainage, although some patients improve spontaneously in the first 24 h. 
Global cerebral ischaemia 
The most likely explanation is the elevation of the pressure in the cerebrospinal fluid spaces 
to the level of that in the arteries at the time of haemorrhage, resulting in a prolonged period 
of global cerebral ischemia. Such an immediate and potentially lethal arrest of the 
circulation to the brain is indeed suggested by autopsy evidence and by the recording of 
intracranial pressure or transcranial Doppler sonography at the time of recurrent aneurismal 
haemorrhage (19, 78). This is quite distinct from delayed ischaemia, which is either focal or 
multifocal (see below). 
Cerebral vasospasm 
The most feared complication of SAH is a form of delayed-onset cerebral arterial narrowing, 
known as VSP (13). Angiographic VSP is detected in 50%-70% of patients in the first two 
weeks after SAH (94). In about one-half of cases, angiographic VSP manifests itself by the 
occurrence of a delayed ischemic neurological deficit, which may resolve or progress to 
permanent cerebral infarction (53). The development of delayed ischemic deficit (DID) is 
still considered to be the major cause of morbidity and mortality in those patients who 
survive long enough to reach the neurosurgical unit. In a recent large multicentre study, 
DID killed 7% of patients with aneurismal SAH and left another 7% with severe permanent 
neurological deficits (42). 
  
Fig. 5. Left carotid DSA performed postoperatively and demonstrating cerebral vasospasm 
affecting both ACA and MCA. 
9.7 Treatment guidelines for ruptured IA 
9.7.1 The prevention of rebleeding 
9.7.1.1 Antifibrinolytic drugs 
Medical treatment for preventing rebleeding has not yet been successful; treatment with 
antifibrinolytic agents does reduce the rebleed rate, but fails to improve overall outcome. 
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A systematic review of antifibrinolytic agents included eight trials published before 2000 
that met predefined inclusion criteria and totalled 937 patients (76). By far the largest study 
was a Dutch-Scottish trial (89). In this meta-analysis, antifibrinolytic treatment did not 
provide any evidence of benefit on outcome. The risk of rebleeding was significantly 
reduced by antifibrinolytic therapy, but this was offset by a similar increase of the risk of 
secondary cerebral ischaemia. 
9.7.1.2 Operative clipping of the aneurysm 
The results of operative treatment were poor until advances in microsurgical techniques and 
neuroanaesthesia in the late 1960s allowed neurosurgeons to successfully treat the majority 
of intracranial aneurysms. The goal for surgical treatment of intracranial aneurysms is to 
eliminate the aneurysm from the circulation while preserving blood flow through the parent 
artery and branch vessels. This treatment is best accomplished by direct clip placement 
across the aneurysm neck. 
  
  
Fig. 6. Illustration of the surgical clipping of a basilar tip aneurysm.  
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9.7.1.2.1 Technical aspects of the surgical repair of ruptured aneurysms 
An operative approach must take into account the location of the aneurysm, and it should 
allow minimal brain retraction. According to Yasargil (101), the most useful approaches are: 
1) pterional craniotomy for aneurysms of the anterior circulation and upper basilar artery; 2) 
paramedian frontal craniotomy for pericallosal artery aneurysms; 3) lateral suboccipital 
craniotomy for aneurysms of the vertebral circulation below the origin of the superior 
cerebellar arteries. The clips for the temporary occlusion of the parent artery have a low 
closing force so as not to cause permanent damage to the vessel wall. To achieve permanent 
clipping, there are multiple choices of clips of different sizes, shapes and closing forces. The 
modern clips are MRI compatible. 
Using gentle brain retraction, the arachnoid cisterns are entered with sharp dissection and 
finally the aneurysm and the adjacent vessels are exposed with a meticulous dissection. 
Prior to the application of the clip, the aneurysm neck must be free of adhesions to the 
surrounding arteries and neural structures. In narrow-necked aneurysms, the clip can be 
placed across the aneurysm neck. However, in complex aneurysms several clips may be 
needed to appropriately occlude the aneurysm in a stepwise manner. Although most 
aneurysms are amenable to clipping, their size, location, morphology and the technical 
difficulties encountered may sometimes prevent the procedure. Alternative techniques for 
treating these unclippable aneurysms include proximal vessel occlusion with or without 
extracranial intracranial (EC IC) bypass, trapping, wrapping and excision of the aneurysm. 
9.7.1.2.2 The timing of the surgical treatment of ruptured aneurysms 
The optimal timing for the surgical treatment of acutely ruptured aneurysms has been 
under constant investigation and is the subject of major controversy. In the 1960s, operative 
treatment was still generally delayed for 3 to 4 weeks following SAH so that the brain could 
recover from the acute effects of SAH. However, mortality and morbidity during the 
waiting period was high because of the occurrence of VSP and rebleeding (43). An operation 
during an early phase (within 72 hours following SAH) or even during the acute phase 
(within 24 hours following SAH) was considered justifiable in order to prevent early 
rebleeding and allow for the aggressive treatment of VSP, and thus improve the outcome for 
the patients. 
In a randomised trial of the timing of the operation performed, 216 patients were allocated 
to operation within 3 days, after 7 days or else in the intervening period (64). The outcome 
tended to be better with the early operations rather than after intermediate or late 
operations, but the difference was not statistically significant. The same result - i.e., no 
difference in outcome after early or late operations - has emerged from various 
observational studies: a multi-centre study from North America (43) and a single institution 
review in Cambridge, UK (96). The US study found the worst outcome among patients 
operated on between day 7 and day 10 after the initial haemorrhage. This disadvantageous 
period for performing the operation in the second week after SAH coincides with the peak 
time of cerebral ischaemia and cerebral vasospasm, both phenomena being most common 
between days 4-12. 
Although the data available is not consistent, early surgery for patients in a good 
preoperative clinical grade (Hunt&Hess Gr I-III) has gradually been accepted as a treatment 
policy by many institutions. Delayed surgery for patients in a poor preoperative clinical 
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grade, however, may be advisable unless immediate surgical intervention is required 
because of large haematoma or severe hydrocephalus. 
9.7.1.3 Endovascular treatment of ruptured intracranial aneurysms 
Until a few years ago, endovascular treatment was restricted to patients in whom the 
aneurysm was unsuitable for clipping because of the size or location of the aneurysm, or in 
whom surgical clipping was contraindicated because of the general medical condition of the 
patient. Since the introduction of controlled detachable coils for the endosaccular packing of 
aneurysms (20), endovascular embolisation is increasingly used. In some institutes, 
endovascular embolisation is even proposed as the initial method of treatment (7). 
The Guglielmi Detachable Coil system 
In 1991, Guglielmi et al. (20) introduced an electrically detachable coil system (GDC) that 
permitted the readjustment of the coil position before its final detachment. The GDC system 
consists of a platinum coil attached to a stainless steel delivery wire (pusher). The pusher is 
coated for electrical isolation with the exception of the most distal part: the detachment 
zone. A guiding catheter is used in advancing to the ICA or the vertebral artery. A 
microcatheter with 2-tip-markers and a guidewire are used for hyperselective 
catheterisation of the aneurismal sac. The distal end of the microcatheter is shaped with 
steam to tailor the vascular geometry before catheterisation. Digital road mapping may be 
used so as not to touch the aneurismal wall with the guidewire or catheter. A continuous 
pressurised flush of heparinised saline is maintained in both the guiding catheter and the 
microcatheter. The aneurysm sac is then filled with coils of selected shapes and sizes. The 
system allows for the removal of the coil as well as the repositioning of the mesh to an 
optimal position. When the coil is seen to be in a suitable position inside the aneurysm, a 
positive direct electric current is applied to the proximal end of the stainless steel guidewire. 
The current provokes thrombus formation in the aneurismal cavity and dissolves the 
uninsulated stainless steel coil closest to the platinum coil, resulting in the detachment of the 
coil. 
  
Fig. 7. Of c: Illustration of the oiling procedure with coils filling the aneurismal cavity. 
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Numerous observational studies have published complication rates, occlusion rates and short-
term follow-up results. These have been summarised - up to March 1997 - in a systematic 
review of 48 eligible studies of 1383 patients (4). Permanent complications in the procedure 
occurred in 3.7% of 1256 patients in whom this was recorded (95% CI 2.7%-4.9%). A >90% 
occlusion of the aneurysm was achieved in almost 90% of patients. The most frequent 
complication was procedure-related ischaemia, even if patients were treated with heparin. The 
second most frequent complication was aneurysm perforation, which occurred in 2% of 
patients. Most of the aneurysms treated with controlled detachable coils were located at the 
basilar artery, followed by the carotid and anterior communicating arteries. Pericallosal 
arteries are difficult to reach and another problematic site is the trifurcation of the middle 
cerebral artery because one or more of the branches often originate from the aneurysm. 
9.7.1.4 Clipping versus coiling 
Indirect comparisons between endovascular and surgical treatment are inappropriate, if 
only because there are so many differences in study design and among the patients and 
aneurysms. Moreover, the rerupture of aneurysms may occur even months after apparently 
successful coiling (52), and the long-term rates of rebleeding after endovascular coiling still 
need to be established. A first report from a single centre in which >300 patients were 
followed-up after aneurysm embolisation for a median period of almost 2 years showed 
rebleeding rates of 0.8% in the first year, 0.6% in the second year and 2.4% in the third year, 
with no rebleeding in subsequent years (5).  
Similarly  surgical treatment is not always definitive: in a retrospective review of 
postoperative angiograms in a series of 66 patients with ruptured aneurysms and 12 
additional aneurysms, all treated by surgical clipping, 8% of patients showed aneurysms 
with a residual lumen or aneurysms that were previously undetected (51). Controlled trials 
are urgently needed in patients with aneurysms for which it is uncertain whether surgical 
clipping or endovascular coiling should be the preferred treatment. The first such study, 
although a small one (109 patients), found no difference in outcome at 3 months between the 
surgical group and the endovascular group for patients with SAH. All of the patients were 
suitable candidates for both endovascular and surgical treatment and were randomly 
assigned to undergo coil embolisation (n = 52) or surgical ligation (n = 57) (88). 
The International Subarachnoid Aneurysm Trial (ISAT), funded by the UK’s Medical 
Research Council (56), is the first large multi-centre randomised study in the world to 
compare the two methods. The ISAT trial enrolled 2143 patients with ruptured intracranial 
aneurysms in 43 neurosurgical centres in Europe, North America and Australia, and 
randomly assigned them to neurosurgical clipping (n = 1070) or GDC coils (n = 1073). 
Because interim analysis demonstrated a striking difference between these groups in favour 
of coiling, the trial was stopped short of its planned goal of 2500 patients. At 1 year follow-
up, the risk of death or significant disability (Rankin score 3-6) was 30.6% in the 
neurosurgical group compared to 23.7% in the endovascular group. There was a 6.9% 
absolute and 22.6% relative risk reduction in favour of coiling. Many patients were screened 
but excluded from the study. Of the 9559 patients initially assessed, only 20% were actually 
enrolled. In the remainder, a decision was made that clipping or coiling was clearly more 
favourable, and thus the patient could not be subjected to a random treatment choice. 
Considerable bias could have been introduced into the study during this screening process. 
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The ISAT patients are not completely representative of the SAH population at large. 88% 
were of good clinical status (Hunt and Hess grade I or II), 93% of aneurysms were 10 mm or 
smaller in diameter and 97% were in the anterior circulation. The generalisability of the 
ISAT data is therefore limited. There was a significant occurrence of post-treatment 
rebleeding. This was found in 2.4% (26/1048) of endovascular cases compared with 1.0% 
(10/994) of clipped patients. While these results clearly favour neurosurgery, such an 
incidence of incompletely treated aneurysms is unusual for either therapy in experienced 
hands. In conclusion, the ISAT tells us that in patients with a ruptured intracranial 
aneurysm - for which endovascular coiling and neurosurgical clipping are therapeutic 
options - the outcome in terms of survival free from disability at 1 year is significantly better 
with endovascular coiling. Long-term follow-up is very important since rebleeding rates 
were found to be significantly higher in patients undergoing endovascular coiling. 
9.7.2 The prevention of vasospasm 
Angiographic VSP is detected in 50%-70% of patients within the first two weeks after SAH 
(94). In about one-half of cases, angiographic VSP manifests itself by the occurrence of a 
delayed ischemic neurological deficit (53). Delayed cerebral ischaemia (DID) is still 
considered to be the major cause of morbidity and mortality in those patients who survive 
long enough to reach the neurosurgical unit. Despite many years of intensive research, the 
pathogenesis of secondary cerebral ischaemia following SAH has not been elucidated. It is a 
generally held belief that after haemorrhage a thus far unidentified factor is released in the 
subarachnoid space, which induces vasoconstriction and thereby secondary ischaemia. Also, 
an often quoted study from Boston (of 41 patients in total) postulates a close relationship 
between the location of subarachnoid blood and the 'thickness' of the clot on the one hand, 
and the occurrence of vasospasm and delayed cerebral ischaemia on the other (46). Several 
observations argue against this popular notion. Firstly, the presence of subarachnoid blood, 
though a powerful predictor of delayed cerebral ischaemia, is not in itself a sufficient factor 
for the development of secondary ischaemia - secondary ischaemia does not occur in 
patients with a perimesencephalic (non-aneurismal) SAH (74) and it is rare in patients with 
SAH secondary to intracerebral haematoma or a ruptured arteriovenous malformation. 
Secondly, in a larger series of patients than in the Boston study, the site of delayed cerebral 
ischaemia did not correspond with the distribution or even with the side of subarachnoid 
blood (30). Thirdly, many patients with vasospasm never develop secondary ischaemia. 
These observations collectively suggest not only the presence of subarachnoid blood per se, 
but also that its combination with other factors determines whether and where secondary 
ischaemia will develop. 
Classically, the clinical symptoms of VSP have consisted of the impairment of 
consciousness, confusion, disorientation and worsening neurological deficits such as 
dysphasia and hemiplegia. The clinical diagnosis of VSP is traditionally based on the time of 
the onset of the deficits, the rate of the development of the deficits (hours), the nature of the 
deficits and the exclusion of other factors that may cause the gradual deterioration of the 
patient or focal neurological signs. The diagnosis is therefore not always definitive. It is 
especially difficult to differentiate symptoms of VSP from other causes that worsen the 
clinical state in patients with impaired consciousness. 
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Despite this lack of pathophysiological insight, some progress has been made in the 
prevention of secondary ischaemia after aneurismal SAH through changes in general 
medical care (notably, increased fluid intake and the avoidance of antihypertensive drugs) 
as well as through specific drug treatment. Transcranial Doppler sonography may suggest 
impending cerebral ischaemia by means of the increased blood flow velocity from arterial 
narrowing in the middle cerebral artery or in the posterior circulation; however, narrowing 
in distal branches often escapes detection. Only velocities >120 cm/s or >200 cm/s are 
reasonably accurate in excluding or predicting delayed ischaemia, but almost 60% of 
patients are in the intermediate range (92). 
Early surgery 
Early surgery was introduced after it was considered that the early clipping of the aneurysm 
not only prevented rebleeding but also allowed for the surgical removal of spasmogenic clot 
from the basal cisterns (80). The aim of intrathecal fibrinolytic treatment after SAH is to 
promote the rapid dissolution of blood clot prior to haemolysis and the release of 
spasmogenic intermediates. 
The management of blood pressure 
The management of hypertension is a difficult issue in patients with SAH, especially if their 
blood pressure rises above 200/110 mmHg. Following intracranial haemorrhage, the range 
between the upper and lower limits of the autoregulation of cerebral blood flow becomes 
narrower, which makes the perfusion of the brain more dependent on arterial blood 
pressure. Consequently, the aggressive treatment of surges of blood pressure entails a 
definite risk of ischaemia in areas with a loss of autoregulation. The rational approach 
would, therefore, be to advise against treating hypertension following aneurismal rupture. 
An observational study from the 1980s showed that the rate of rebleeding was lower but 
that the rate of cerebral infarction was higher than in untreated patients (99). A further 
observational study suggested that the combined strategy of avoiding antihypertensive 
medication and increasing fluid intake may decrease the risk of cerebral infarction (24). 
Fluid balance and electrolytes 
Fluid management in SAH is important for preventing a reduction in plasma volume, which 
may contribute to the development of cerebral ischaemia. In approximately one-third of 
patients, plasma volume drops by >10% within the preoperative period, which is 
significantly associated with a negative sodium balance. Moreover, fluid restriction in 
patients with hyponatraemia is associated with an increased risk of cerebral ischaemia. 
Fluid restriction was applied in the past because hyponatraemia was erroneously attributed 
to water retention via the inappropriate secretion of antidiuretic hormones. 
Despite the incomplete evidence, it seems reasonable to prevent hypovolaemia. We favour 
giving 2.5-3.5L/day of normal saline, unless contraindicated by signs of impending cardiac 
failure 
Calcium antagonists 
Initially, the rationale for the use of calcium antagonists in the prevention or treatment of 
secondary ischaemia was based on the assumption that these drugs reduce the frequency of 
vasospasm by counteracting the influx of calcium in the vascular smooth muscle cell. 
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Clinical trials have been undertaken with three types of calcium antagonists: nimodipine, 
nicardipine and AT877 (of which nimodipine is the most extensively studied and used). A 
recent systematic review of all randomised controlled trials on calcium antagonists in 
patients with SAH showed a significant reduction in the frequency of poor outcomes, which 
resulted from a reduction in the frequency of secondary ischaemia (12). When analysed 
separately, the nimodipine trials showed a significant reduction in the frequency of poor 
outcomes, but the nicardipine and AT877 trials did not. While, nicardipine and AT877 
significantly reduce the frequency of vasospasm, the nimodipine trials showed only a trend 
towards the reduction of vasospasm, despite the fact that a larger number of patients were 
included. In brief, the administration of nimodipine improves outcomes in patients with 
SAH, but it is uncertain whether nimodipine acts through neuroprotection or through 
reducing the frequency of vasospasm, or both. Nicardipine and AT877 definitely reduce the 
frequency of vasospasm, but the effect on the overall outcome remains unproven, which 
again underlines the weak relation between vasospasm and outcomes. 
Since the systemic administration of vasoactive drugs has been associated with significant side 
effects and insufficient efficacy, the intrathecal administration of nicardipine prolonged-release 
implants (NPRI) has been developed. At the time of the surgical clipping of the ruptured 
aneurysm, NPRIs are positioned next to the large cerebral arteries. Several clinical protocols 
revealed that NPRIs dramatically reduce the incidence and severity of angiographic 
vasospasm, which was matched by a reduction in cerebral infarction and delayed ischaemic 
neurologic deficit. On average, the incidence of angiographic vasospasm decreased from 
approximately 70% to less than 10%. Its efficacy seemed to be dose-dependent and reduced for 
peripheral vasospasm, and large controlled trials are needed to further confirm these results. 
9.7.3 The treatment of delayed cerebral ischaemia 
Treatment with hypervolaemia, haemodilution and induced hypertension - the so-called 
‘triple H therapy’ - has become widely used, although evidence from clinical trials is still 
lacking. In a series of patients with progressive neurological deterioration and 
angiographically confirmed vasospasm, the deficits could be permanently reversed in 43 of 
58 cases (41). In 16 patients who had responded to this treatment, the neurological deficits 
recurred when the blood pressure transiently dropped but again resolved when the 
pressure increased. The most plausible explanation for these phenomena is a defect of 
cerebral autoregulation that makes the perfusion of the brain passively dependent on 
systemic blood pressure. The risks of deliberately increasing the arterial pressure and 
plasma volume include the rebleeding of an unclipped aneurysm, increased cerebral 
oedema or haemorrhagic transformation in areas of infarction, myocardial infarction and 
congestive heart failure. 
Recent developments in endovascular treatments have enabled the direct dilatation of 
constricted cerebral arteries by transluminal angioplasty (48). Since angioplasty is not 
effective in dilating the distal arteries, superselective intra-arterial papaverine 
administration was proposed as an alternative or adjunctive method of treatment (40). 
Subsequently, the use of intra-arterial papaverine has been found to not provide additional 
benefits when compared with the medical treatment of vasospasm alone (68). Studies 
comparing the effects of transluminal angioplasty with intra-arterial papaverine have found 
angioplasty to be superior in reversing DID and in improving CBF (11, 14). 
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9.8 Other complications of subarachnoid haemorrhage 
Hydrocephalus 
Acute hydrocephalus is frequently associated with SAH. In the International Cooperative 
Study on the Timing of Aneurysm Surgery (43), early hydrocephalus was initially noted in 
15% of the overall population (3521 patients). During the course of treatment, 18% of the 
patients received ventricular CSF drainage, 8% had lumbar CSF drainage and 8% received a 
permanent shunt device. In the surgical series of 835 consecutive patients with aneurismal 
SAH, Tapaninaho et al. (81) reported a frequency of 35% of early hydrocephalus. 10% of 
patients finally developed a shunt-dependent hydrocephalus. Severe bleeding into the CSF 
cisterns or intraventricularly was the basic prognostic factor in the development of chronic 
hydrocephalus. Shunt-dependent hydrocephalus had a clear adverse effect on outcomes. 
Seizures 
There was frequency of 4.5% in the occurrence of seizures during the primary hospital course 
in the International Cooperative Study on the Timing of Aneurysm Surgery (43). In the series 
of Hernesniemi et al. (27), epilepsy was seen in approximately 14% of patients with acute 
aneurismal SAH who were treated surgically and who were still alive two months after 
treatment. Keranen et al. (45) reported an overall frequency of 14% of late epilepsy in 
surgically treated patients with supratentorial aneurysms; 2.5% in patients with preoperative 
Hunt&Hess grade I and 33% in patients with Hunt&Hess grade III-V. Ukkola et al. (83) 
reported a lower frequency of 8% of secondary epilepsy in their series of 183 consecutive 
patients operated on for ruptured aneurysms. They noted that the development of secondary 
epilepsy was associated with MCA aneurysms, temporary clipping during surgery, the 
wrapping technique used to treat the aneurysm and postoperative angiographic VSP. 
10. Screening for occult IA 
Screening for occult IA is a complex issue, it being of arguable effectiveness and very 
expensive. Unless a screening test is very highly sensitive and specific, inexpensive, easy to 
administer and can be delivered in practice to the appropriate population successfully, it is 
unlikely to produce worthwhile results and is more likely to increase health care costs and 
stress among the population and healthcare staff alike. Furthermore, unless one can 
differentiate between diseases that are likely to remain sub-clinical and those that are likely 
to cause significant symptoms, the treatment of disease following a screening program may 
have less of an impact than expected on cumulative mortality rates. In the case of 
intracranial aneurysms, because we cannot yet tell when aneurysms are going to rupture or 
form de novo, it would be difficult to know which to treat, which to leave alone and how 
often to screen, etc. The stress of being screened is difficult to quantify and probably 
depends in part upon the seriousness (in the minds of the screened population) of the 
disease being sought. 
As with any screening exercise, multiple factors need to be considered, such as raising 
anxieties in the patient or the patient's family, confidentiality issues, 'the right not to know', 
the problems raised by false-positive and false-negative diagnoses, what age to start 
investigating patients and how often to repeat the investigations, etc. For intracranial 
aneurysms, many of these factors remain uncertain. There may be financial costs for the 
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individuals who are screened. If conservative management is advised, knowledge of the 
presence of an aneurysm may be worrying to the individual concerned (and to his/her 
family and employer). Bearing all of these factors in mind, ignorance (of the presence or 
absence of an aneurysm) may actually be the best course of action for an individual at 
present. 
Several groups have recommended screening for intracranial aneurysms in high-risk 
groups, namely ADPKD patients and those with a strong family history of aneurismal SAH 
(47, 49, 98). The efficacy of screening for aneurysms depends crucially on certain parameters 
relating to the natural history of aneurysms, particularly the prevalence and the annual risk 
of rupture. The analysis of rupture risk is complicated further by the pattern of aneurysm 
rupture - some aneurysms appear to develop and rupture rapidly whilst others stabilise 
(38). Screening will tend to detect the low-risk stable type rather than the high-risk 
aneurysms. The other critical consideration is the safety and effectiveness of treating a silent 
aneurysm in a healthy patient. A recent study found that the screening of individuals with a 
family history of L2 first-degree relatives with intracranial aneurysm with magnetic 
resonance angiography (MRA), followed by digital subtraction angiography (DSA) and 
surgery, is not an effective way of reducing morbidity and mortality from ruptured 
intracranial aneurysm (8). 
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